Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong
- PMID: 35966846
- PMCID: PMC9363753
- DOI: 10.3389/fmed.2022.948149
Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong
Keywords: COVID-19; Chinese medicine; Jinhua Qinggan Granules (JHQG); Omicron; SARS-CoV-2.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Hong Kong now has the world's highest Covid-19 death rate . What happened, and how can this be fixed? (2022). Available online at: https://www.scmp.com/news/hong-kong/health-environment/article/3169331/h... (accessed May 02, 2022).
-
- Kim L, Garg S, O'Halloran A, Whitaker M, Pham H, Anderson EJ, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019(COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. (2021) 72:e206–14. 10.1093/cid/ciaa1012 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
